About : Next generation biotech company
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation tissue protective therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug Tiprelestat.
5 Facts about tiakis
Located in Kiel in the north of Germany
More than 20 years of experience
Lead by a dynamic and multi-disciplinary team
Trusted by renowned partners all over the world
Selected as a partner in federal and state driven R&D programs
“Incorporated in 2000 with full focus on its novel therapy approach“
Our Values : Driven by the vision to improve human health
We seek to shift the treatment paradigm towards an early onset of treatment approach that alleviates the suffering and morbidity of most patients undergoing highly invasive surgery by protecting them from inflammatory organ damage and failure.